Morgan Stanley lowered the firm’s price target on Nucor (NUE) to $166 from $170 and keeps an Overweight rating on the shares. The firm is updating estimates following Q3 earnings to include the company Q4 guidance and commentary.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUE:
- Closing Bell Movers: Medpace down 11% after cutting FY24 revenue guide
- NUE Earnings: Nucor Slides after Q3 EPS Misses Estimates
- Nucor’s Q3 Earnings Drop but Strategic Growth Persists
- Nucor reports Q3 adjusted EPS $1.49, consensus $1.47
- Nucor expects earnings in Q4 to decrease compared to Q3 EPS of $1.05